GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] A1c 9.1 → 5.4, full table, 14 months — 44 comments in the full submission. View in context.
789
c/t2dglp1·submitted 3 days ago by u/britt_abubakar

[Results] A1c 9.1 → 5.4, full table, 14 months

Resultsbranch of 8 comments

A1c 9.1 → 5.4, full table, 14 months. Posting the boring middle of the process, because the internet is full of the start and the end and nothing else. Figures up front so nobody has to dig: 14 months. On hypoglycaemia, because the risk gets attributed to the wrong thing constantly. Incretin-based agents stimulate…

Read the full submission and all 44 comments →

This branch

8 comments, started 2 days ago
u/nadia_norgaard98 points·2 days ago

Certain conditions affect A1c independently of glycaemia. If a result looks inconsistent with the sensor data, that is a question for whoever manages your care rather than for this board.

replysharereportpermalink
[deleted]39 points·2 days ago

[deleted]

replysharereportpermalink
u/nhs_waitlist_nUK27 points·2 days ago

Postprandial excursions flattened out first and the fasting number took months to follow. Nobody had told me to expect that order.

replysharereportpermalink
u/laila_wikstrom141 points·2 days ago

The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a comparison.

replysharereportpermalink
u/sock_puppet_spotter96 points·2 days ago

The diabetes and obesity programmes are separate, with different populations and different primary endpoints.

laila_wikstrom is right that the fasting number moves last. Knowing that in advance saves months of worry.

replysharereportpermalink
load more comments (3) →

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.